NKTR
Price:
$60.98
Market Cap:
$1.19B
Nektar Therapeutics is a biopharmaceutical firm dedicated to the global discovery and advancement of therapies addressing significant unmet medical requirements. Central to its robust pipeline is Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist. This drug is currently in Phase 3 clinical trials for metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, head and neck squamous cell carcinoma, and adjuvant melanoma. It is also being evaluated in Phase 2 for renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; Phase 1/2A for head and neck squamous cell carcinoma; Phase 1/2 for various solid tumors; and Phase 1B for COVID-19. Add...[Read more]
Industry
Biotechnology
IPO Date
1994-05-03
Stock Exchange
NASDAQ
Ticker
NKTR
According to Nektar Therapeutics’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Nektar Therapeutics over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), NKTR's Dividend Yield was at its highest in in the June 2016 quarter at 0%. The Dividend Yield was at its lowest in in the June 2016 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Nektar Therapeutics Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0% | 0% |
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
The current Dividend Yield of Nektar Therapeutics (NKTR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Nektar Therapeutics’s Dividend Yield is less than Inhibrx Biosciences, Inc. (0%), less than Atai Beckley Inc. (0%), less than Enliven Therapeutics, Inc. (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than ORIC Pharmaceuticals, Inc. (0%), less than Relay Therapeutics, Inc. (0%), less than Xencor, Inc. (0%), less than Immatics N.V. (0%), less than Amylyx Pharmaceuticals, Inc. (0%), less than Sana Biotechnology, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $1.37B | |
| 0% | $1.49B | |
| 0% | $3.15B | |
| 0% | $1.68B | |
| 0% | $878.86M | |
| 0% | $2.78B | |
| 0% | $937.15M | |
| 0% | $1.31B | |
| 0% | $1.30B | |
| 0% | $876.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nektar Therapeutics using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nektar Therapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Nektar Therapeutics's Dividend Yield?
How is the Dividend Yield calculated for Nektar Therapeutics (NKTR)?
What is the highest Dividend Yield for Nektar Therapeutics (NKTR)?
What is the 3-year average Dividend Yield for Nektar Therapeutics (NKTR)?
What is the 5-year average Dividend Yield for Nektar Therapeutics (NKTR)?
How does the current Dividend Yield for Nektar Therapeutics (NKTR) compare to its historical average?